Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ViewRay, Inc. (VRAY : NSDQ)
 
 • Company Description   
ViewRay Inc. is a medical device company. The company develops advanced radiation therapy technology for the treatment of cancer. MRIdian system provides continuous soft-tissue imaging during treatment. ViewRay Inc. is headquartered in Oakwood Village, Ohio.

Number of Employees: 267

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.20 Daily Weekly Monthly
20 Day Moving Average: 2,243,936 shares
Shares Outstanding: 180.46 (millions)
Market Capitalization: $577.47 (millions)
Beta: 1.12
52 Week High: $8.25
52 Week Low: $2.39
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -8.05% 0.35%
12 Week -8.57% -3.74%
Year To Date -41.92% -32.30%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2 THERMO FISHER WAY
-
OAKWOOD VILLAGE,OH 44146
USA
ph: 440-703-3210
fax: 800-417-3459
investors@viewray.com http://www.viewray.com
 
 • General Corporate Information   
Officers
Scott Drake - Chief Executive Officer; President and Director
Daniel Moore - Chairman
Zachary Stassen - Chief Financial Officer
Caley Castelein - Director
B. Kristine Johnson - Director

Peer Information
ViewRay, Inc. (ABMD)
ViewRay, Inc. (DMDS)
ViewRay, Inc. (CPWY.)
ViewRay, Inc. (EQUR)
ViewRay, Inc. (ECIA)
ViewRay, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 92672L107
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 180.46
Most Recent Split Date: (:1)
Beta: 1.12
Market Capitalization: $577.47 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.15 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.60 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.91
Price/Cash Flow: -
Price / Sales: 7.86
EPS Growth
vs. Year Ago Period: 17.65%
vs. Previous Quarter: 12.50%
Sales Growth
vs. Year Ago Period: 21.58%
vs. Previous Quarter: -7.41%
ROE
03/31/22 - -76.00
12/31/21 - -74.48
09/30/21 - -79.12
ROA
03/31/22 - -37.81
12/31/21 - -38.49
09/30/21 - -40.27
Current Ratio
03/31/22 - 3.17
12/31/21 - 3.72
09/30/21 - 3.72
Quick Ratio
03/31/22 - 2.84
12/31/21 - 3.33
09/30/21 - 3.08
Operating Margin
03/31/22 - -148.47
12/31/21 - -156.95
09/30/21 - -159.97
Net Margin
03/31/22 - -148.47
12/31/21 - -156.95
09/30/21 - -159.97
Pre-Tax Margin
03/31/22 - -148.47
12/31/21 - -156.95
09/30/21 - -159.97
Book Value
03/31/22 - 0.82
12/31/21 - 1.03
09/30/21 - 0.72
Inventory Turnover
03/31/22 - 2.17
12/31/21 - 1.82
09/30/21 - 1.59
Debt-to-Equity
03/31/22 - 0.33
12/31/21 - 0.32
09/30/21 - 0.49
Debt-to-Capital
03/31/22 - 26.52
12/31/21 - 26.38
09/30/21 - 36.36
 

Powered by Zacks Investment Research ©